Travere Therapeutics (TVTX) Q3 2024 Earnings

1AugConfirmed
Q3 2023
Q4 2023
Q2 2024
Q3 2024
-1.76
-0.42
0.93
2.27

Details

Expected EPS
-0.790991
Actual EPS
-0.91
Surprise EPS
-0.12
Surprise Percent
+15.05%

Description

Travere Therapeutics (TVTX) has reported earnings of -0.91 per share for Q3 2024.

0 Comments

Share your thoughts